The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment - Concepedia

Concepedia

Publication | Closed Access

The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment

25

Citations

21

References

2020

Year

Hossein Poustchi, Sara Majd Jabbari, Shahin Merat, Amir‐Houshang Sharifi, Ali Akbar Shayesteh, Elahe Shayesteh, Mohammad Minakari, Mohammad Reza Fattahi, Maryam Moini, Fatemeh Roozbeh,

Journal of Gastroenterology and Hepatology

Abstract

The combination of sofosbuvir and daclatasvir is an effective and safe treatment for patients infected with all genotypes of hepatitis C who have severe renal impairment, including patients on hemodialysis.

References

	Year	Citations

Page 1